- 米国企業
- Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals, Inc.AMPH
| 2014年
12月31日 | 2015年
12月31日 | 2016年
12月31日 | 2017年
12月31日 | 2018年
12月31日 | 2019年
12月31日 | 2020年
12月31日 | 2021年
12月31日 | 2022年
12月31日 | 2023年
12月31日 |
|---|
| Net income attributable to Amphastar Pharmaceuticals, Inc. | - | - | - | - | -7 | 47 | 1 | 63 | 91 | 138 |
|---|
| Loss (gain) on disposal of assets | - | - | - | - | - | -1 | -0 | -0 | -0 | -0 |
|---|
| Gain on deconsolidation of subsidiary | - | - | - | - | - | - | - | 14 | - | - |
|---|
| Impairment of long-lived assets | - | - | - | - | - | - | - | - | - | 3 |
|---|
| Gain on interest rate swaps and foreign currency transactions, net | - | - | - | - | - | - | - | - | 2 | -5 |
|---|
| Gain on deconsolidation of subsidiary | - | - | - | - | - | - | - | 14 | - | - |
|---|
| Depreciation expense | 13 | 11 | 12 | 13 | 15 | 17 | 20 | 22 | 24 | 25 |
|---|
| Gain on interest rate swaps and foreign currency transactions, net | - | - | - | - | - | - | - | - | 2 | -5 |
|---|
| Amortization Of Intangible Assets | 2 | 2 | 3 | 3 | 2 | 1 | 1 | 1 | 1 | 13 |
|---|
| Depreciation expense | 13 | 11 | 12 | 13 | 15 | 17 | 20 | 22 | 24 | 25 |
|---|
| Operating lease right-of-use asset amortization | - | - | - | - | - | - | - | 3 | 4 | 4 |
|---|
| Amortization Of Intangible Assets | 2 | 2 | 3 | 3 | 2 | 1 | 1 | 1 | 1 | 13 |
|---|
| Equity in losses of unconsolidated affiliate | - | - | - | - | - | - | - | -0 | -1 | -2 |
|---|
| Operating lease right-of-use asset amortization | - | - | - | - | - | - | - | 3 | 4 | 4 |
|---|
| Share-based compensation | 8 | 12 | 15 | 17 | 17 | 17 | 20 | 19 | 18 | 20 |
|---|
| Amortization of Debt Issuance Costs | - | - | - | - | - | - | - | - | - | 11 |
|---|
| Changes in reserve for uncertain tax positions | -0 | -0 | 0 | 0 | -0 | 3 | 1 | 2 | 1 | -1 |
|---|
| Equity in losses of unconsolidated affiliate | - | - | - | - | - | - | - | -0 | -1 | -2 |
|---|
| Changes in deferred taxes, net | 9 | -8 | 4 | -4 | 1 | -5 | 0 | -2 | 16 | 13 |
|---|
| Share-based compensation | 8 | 12 | 15 | 17 | 17 | 17 | 20 | 19 | 18 | 20 |
|---|
| Accounts receivable, net | -1 | 11 | -6 | 8 | 16 | -7 | 20 | 15 | 10 | 26 |
|---|
| Inventories | -7 | -10 | 10 | -19 | 6 | 41 | -15 | -1 | 12 | 2 |
|---|
| Prepaid expenses and other assets | 0 | 1 | -1 | 5 | -1 | 4 | 2 | -4 | 2 | 3 |
|---|
| Income tax refunds, deposits, and payable, net | - | - | - | 12 | -4 | -1 | 1 | -8 | 5 | 3 |
|---|
| Operating lease liabilities | - | - | - | - | - | -3 | -4 | -3 | -3 | -4 |
|---|
| Accounts payable and accrued liabilities | 6 | -3 | -1 | 7 | 29 | -12 | 21 | 3 | -1 | 13 |
|---|
| Changes in reserve for uncertain tax positions | -0 | -0 | 0 | 0 | -0 | 3 | 1 | 2 | 1 | -1 |
|---|
| Changes in deferred taxes, net | 9 | -8 | 4 | -4 | 1 | -5 | 0 | -2 | 16 | 13 |
|---|
| Accounts receivable, net | -1 | 11 | -6 | 8 | 16 | -7 | 20 | 15 | 10 | 26 |
|---|
| Inventories | -7 | -10 | 10 | -19 | 6 | 41 | -15 | -1 | 12 | 2 |
|---|
| Prepaid expenses and other assets | 0 | 1 | -1 | 5 | -1 | 4 | 2 | -4 | 2 | 3 |
|---|
| Income tax refunds, deposits, and payable, net | - | - | - | 12 | -4 | -1 | 1 | -8 | 5 | 3 |
|---|
| Operating lease liabilities | - | - | - | - | - | -3 | -4 | -3 | -3 | -4 |
|---|
| Accounts payable and accrued liabilities | 6 | -3 | -1 | 7 | 29 | -12 | 21 | 3 | -1 | 13 |
|---|
| Net cash provided by operating activities | - | - | - | 39 | 38 | 42 | 57 | 98 | 89 | 184 |
|---|
| Purchases and construction of property, plant, and equipment | 19 | 14 | 21 | 35 | 47 | 42 | 34 | 27 | 24 | 38 |
|---|
| BAQSIMI acquisition | - | - | - | - | - | - | - | - | - | 506 |
|---|
| Proceeds from the sale of property, plant and equipment | - | 0 | - | - | 0 | - | - | - | 0 | - |
|---|
| Purchases and construction of property, plant, and equipment | 19 | 14 | 21 | 35 | 47 | 42 | 34 | 27 | 24 | 38 |
|---|
| Purchase of investments | - | - | 4 | 6 | 0 | 9 | 14 | 17 | 36 | 145 |
|---|
| Proceeds from the sale of property, plant and equipment | - | 0 | - | - | 0 | - | - | - | 0 | - |
|---|
| Maturity of investments | - | - | 3 | 4 | 0 | - | 12 | 19 | 28 | 39 |
|---|
| Purchase of investments | - | - | 4 | 6 | 0 | 9 | 14 | 17 | 36 | 145 |
|---|
| Payment of deposits and other assets | - | 1 | 5 | 1 | -0 | 0 | 1 | 3 | 1 | -1 |
|---|
| Maturity of investments | - | - | 3 | 4 | 0 | - | 12 | 19 | 28 | 39 |
|---|
| Net cash used in investing activities | - | - | - | -39 | -42 | -51 | -36 | -29 | -33 | -649 |
|---|
| Deposits and other assets | - | 1 | 5 | 1 | -0 | 0 | 1 | 3 | 1 | -1 |
|---|
| Net cash used in investing activities | - | - | - | -39 | -42 | -51 | -36 | -29 | -33 | -649 |
|---|
| Acquisition of additional ownership interest in ANP | - | - | - | - | - | - | 0 | - | - | - |
|---|
| ANP restructuring (see Note 3) | - | - | - | - | - | - | - | 54 | - | - |
|---|
| ANP restructuring (see Note 3) | - | - | - | - | - | - | - | 54 | - | - |
|---|
| Net proceeds from equity plans | - | 14 | 21 | 14 | 9 | 3 | 23 | 16 | 16 | 11 |
|---|
| Net proceeds from equity plans | - | 14 | 21 | 14 | 9 | 3 | 23 | 16 | 16 | 11 |
|---|
| Purchase of treasury stock | 0 | 10 | 10 | 31 | 25 | 22 | 24 | 29 | 40 | 58 |
|---|
| Purchase of treasury stock | 0 | 10 | 10 | 31 | 25 | 22 | 24 | 29 | 40 | 58 |
|---|
| Settlement Of Equity Awards | - | - | - | - | - | - | - | -1 | - | - |
|---|
| Settlement Of Equity Awards | - | - | - | - | - | - | - | -1 | - | - |
|---|
| Debt issuance costs | - | - | - | - | - | - | - | 2 | 0 | 25 |
|---|
| Debt issuance costs | - | - | - | - | - | - | - | 2 | 0 | 25 |
|---|
| Repayments under lines of credit | 40 | - | - | - | - | 0 | - | 1 | - | - |
|---|
| Proceeds from borrowing under lines of credit | 25 | - | - | - | 0 | - | 1 | - | - | - |
|---|
| Proceeds from issuance of long-term debt | 27 | 7 | 10 | 19 | 8 | 4 | 6 | 70 | - | 845 |
|---|
| Repayments under lines of credit | 40 | - | - | - | - | 0 | - | 1 | - | - |
|---|
| Principal payments on long-term debt | 8 | 9 | 15 | 10 | 6 | 6 | 8 | 37 | 2 | 319 |
|---|
| Proceeds from issuance of long-term debt | 27 | 7 | 10 | 19 | 8 | 4 | 6 | 70 | - | 845 |
|---|
| Net cash provided by financing activities | - | - | - | -8 | 25 | -4 | -2 | -37 | -26 | 454 |
|---|
| Principal payments on long-term debt | 8 | 9 | 15 | 10 | 6 | 6 | 8 | 37 | 2 | 319 |
|---|
| Net cash provided by financing activities | - | - | - | -8 | 25 | -4 | -2 | -37 | -26 | 454 |
|---|
| Effect of exchange rate changes on cash | - | - | - | - | - | -0 | 0 | -0 | -0 | -0 |
|---|
| Net (decrease) increase in cash, cash equivalents, and restricted cash | - | - | - | - | - | -13 | 19 | 32 | 30 | -12 |
|---|
| Capital Expenditures Incurred but Not yet Paid | - | - | - | - | - | 11 | 11 | 9 | 5 | 4 |
|---|
| Deferred Payment For Acquisition | - | - | - | - | - | - | - | - | - | 122 |
|---|
| Noncash Operating Lease Right Of Use Asset | - | - | - | - | - | 8 | 5 | 11 | 2 | 11 |
|---|
| Capital Expenditures Incurred but Not yet Paid | - | - | - | - | - | 11 | 11 | 9 | 5 | 4 |
|---|
| Equipment acquired under finance leases | 0 | 0 | 1 | - | 0 | 0 | 0 | 0 | 1 | - |
|---|
| Noncash Operating Lease Right Of Use Asset | - | - | - | - | - | 8 | 5 | 11 | 2 | 11 |
|---|
| Equipment acquired under finance leases | 0 | 0 | 1 | - | 0 | 0 | 0 | 0 | 1 | - |
|---|
| Interest paid, net of capitalized interest | - | - | - | 2 | 2 | 2 | 2 | 2 | 3 | 18 |
|---|
| Income taxes paid | 0 | 0 | 3 | 5 | 0 | 6 | 3 | 8 | 44 | 49 |
|---|